NewsCura

China Banking Corporation

Disclaimer: The research and recommendation below were generated by Claude Fable. Please treat this as one input for your own research — not as the sole basis for any decision to buy or sell a stock.

Last checked
Price
56.2500
Trading status
Normal
Recommendation
Buy (value plus income; watch the cost-to-income jump)Buy
Committee call
Hold
Indices
PSEi

Analysis

CBC - China Banking Corporation

One-line summary: SM Group-controlled bank trading at roughly 5.4x trailing earnings and 0.79x book with a sector-leading ~15.5% ROE and a well-covered, steadily growing dividend, though Q1 2026 profit growth slowed sharply to 4% even as loans grew 16%, a cost-to-income uptick worth watching.

Snapshot
Reviewed July 19, 2026
Index membership PSEi
Price at review P56.25
Recommendation Buy (value-plus-income pick; committee split to Hold this week, see below)
Market cap P151.4B (2.69B shares outstanding, ~58% free float)
Trailing P/E ~5.36x
Forward P/E ~5.22x
Dividend (latest declaration) P2.80/share (P1.80 regular + P1.00 special, based on FY2025 earnings), ~4.98% yield at 56.25
P/B ~0.79x
Capital (in place of D/E) CAR 16.1%, CET1 15.2% (end-2025), both well above BSP minimums of 10% / 6%

Net interest income, fees, and earnings trend

Chinabank's core engine is net interest income (NII), which has compounded consistently: P39.1B (2021), P45.6B (2022), P53.5B (2023), P63.5B (2024), P72.6B (2025), and P75.0B on a trailing-twelve-month basis through Q1 2026. Net income climbed from P15.1B (2021) to P28.0B (2025), an 85% rise in four years, on the back of double-digit loan growth, a wide net interest margin, and rising fee and transactional income (FY2025 total operating income of P75.7B, up 16%).

As with the rest of the sector, the growth rate has been decelerating even before the sharpest slowdown showed up. Net income growth ran 26.6% (2022), 15.2% (2023), 12.7% (2024), and 12.8% (2025), a gentle but steady cooling that tracked EPS growth of 12.69% (2024) and 12.80% (2025). Then Q1 2026 confirmed a much sharper deceleration: net income of P6.8B was up only 4% year on year, even though gross loans grew 16% to P1.1 trillion and NII grew 14% to P19.5B. The gap between strong balance-sheet growth and a near-flat bottom line traces mostly to operating expenses: opex rose 5% to P8.8B in the quarter, but the cost-to-income ratio jumped from 45% (full-year 2025) to 49% (Q1 2026), a meaningful one-quarter move that management attributed to continued investment in "human capital and digital transformation." That is a real cost pressure to track, not obviously a one-off like a trading-gain windfall, and it deserves at least one more quarter of data before concluding it is either transient or structural. As of July 19, 2026, Q2 2026 results have not been released (typically due late July/August), so the cost-to-income jump remains a single-quarter data point with no confirmation either way.

Asset quality, margins, and capital adequacy

Free cash flow is not a meaningful concept for a bank (deposit-taking and lending are the operating business, not investing activity to be netted against operations), so this section substitutes the metrics that actually describe a bank's health.

  • Asset quality: the gross NPL ratio has held steady at 1.6% through FY2025 and Q1 2026, well below the industry average (around 3.2-3.4% over the same period). NPL coverage was 109% at end-2025, improving slightly to 110% in Q1 2026. Coverage above 100% means reserves exceed the bad-loan balance, but it is thinner than some peers (Metrobank, for comparison, runs coverage in the 137-141% range), so Chinabank has less of a buffer if credit costs were to turn.
  • Net interest margin: improved to 4.61% in Q1 2026 from 4.49% a year earlier, and stood at 4.6% for full-year 2025, notably wider than the large universal-bank peer group (Metrobank's NIM was 3.7% in the same period), likely reflecting a loan mix skewed toward higher-yielding consumer and SME lending. A material BSP rate-cutting cycle is the single biggest swing factor working against this margin.
  • Loan growth: gross loans surpassed P1 trillion in 2025 (+13% year on year) and grew 16% year on year in Q1 2026 to P1.1 trillion, faster than the FY2025 pace and faster than Metrobank's comparable 9% growth, driven by demand across both consumer and corporate segments.
  • Capital adequacy: CAR stood at 16.1% and CET1 at 15.2% at end-2025, both comfortably above BSP's 10% CAR / 6% CET1 minimums and, on this single data point, stronger than Metrobank's Q1 2026 levels (CAR 14.9%, CET1 14.2%). No quarterly capital-ratio figure was disclosed for Q1 2026 in the sources reviewed, so the trend direction into 2026 is not yet confirmed; total capital did grow 13% in 2025 alongside book value per share (P71.04, +13%; P71.42 in Q1 2026, +10%), suggesting retained earnings are keeping pace with risk-weighted asset growth so far.
  • Deposits: total deposits reached P1.5 trillion in Q1 2026 (+13% year on year), with CASA (current/savings, the cheap funding) improving to 48% of the total from 46%, a favorable funding-mix trend even as total assets grew to P1.9 trillion (+12%).

Dividend sustainability

Chinabank has raised its total per-share dividend every year for at least five years running: P1.00 (2021), P1.50 (2022), P1.90 (2023), P2.20 (2024), P2.50 (2025), and P2.80 in the latest declaration paid in mid-2026 (a 12% increase, split as P1.80 regular plus P1.00 special, approved alongside the FY2025 results). Against FY2025 EPS of P10.40, that implies a payout ratio of roughly 24%, among the lowest of the PH bank names reviewed in this wiki (Metrobank's is around 45%). That low payout ratio means the dividend is very well covered and there is real room for it to keep growing in line with earnings, but it also means Chinabank is retaining the large majority of profit to fund its faster-than-peer loan growth rather than returning cash to shareholders. Investors buying primarily for current yield will find the ~5% yield modest next to Metrobank's ~7.5%; investors buying for a growing income stream get a cleaner, more consistent five-year raise history here.

ROE

ROE has been consistently strong and rising: 13.48% (2021), 15.09% (2022), 15.46% (2023), 15.56% (2024), 15.55% (2025), essentially plateauing in the mid-teens for the last three years rather than continuing to climb, similar to the pattern seen across PH banks generally. ROA has been stable in the 1.4-1.6% range over the same period. This ROE is meaningfully higher than Metrobank's 12-13% band over the same years, and it is not the product of unusual leverage: capital ratios sit well above regulatory minimums and free float is high (58%), so this reads as a genuinely higher-return franchise rather than a thin-equity-base illusion.

Capital allocation

Capital is being split between funding loan growth that is running faster than peers (16% year on year in Q1 2026), paying a steadily rising but conservatively low-payout dividend (about 24% of earnings), and building capital buffers that, on the one data point available, look stronger than at least one large peer. There is no visible buyback program or major acquisition in the recent record; retained earnings are the primary lever. Ownership is concentrated with the Sy family's SM Group, historically holding roughly 38-42% of the bank between SM Investments Corporation and Sysmart Corporation (with additional related-party holdings), consistent with the current 58% free float figure implying about 42% closely held. Hans Sy has chaired the board since being first elected a director in 1986; Romeo D. Uyan Jr. has been President and CEO since April 2023. A routine executive succession took effect July 16, 2026 (a new Chief Compliance and Governance Officer), not a governance red flag on its own. As with any SM Group-controlled company, minority shareholders do not set capital-allocation policy, but the low, steadily rising payout and conservative capital ratios point to a disciplined rather than promotional approach so far.

Verdict at P56.25 (July 19, 2026)

Buy, unchanged from the July 12 review, though the committee below split to Hold this week and that disagreement is worth taking seriously rather than waving off. The valuation case has not moved: P/E around 5.4x trailing and just over 5x forward, P/B at 0.79x against a mid-teens ROE, and a dividend that, while a modest ~5% yield today, is extremely well covered (24% payout ratio) with a clean five-year record of annual increases. Asset quality is clean (1.6% NPL, well below the sector average) and margins are wide (4.6% NIM, ahead of large-bank peers), while loan growth is running faster than most PH banks reviewed in this wiki. Analyst coverage is thin (one to two analysts tracked by stockanalysis.com and Investing.com) but points toward a consensus target near P86, well above the current price, for whatever that thin sample is worth.

The catch is the same sector-wide theme showing up here as at other PH banks: net income growth has been decelerating for three straight years (26.6% to 12.8%), and Q1 2026 showed a much sharper drop to just 4% growth despite loans growing 16% and NII growing 14%. Here the driver looks less like margin compression and more like a genuine cost-to-income jump (45% to 49% in one quarter), which is either the start of a structural opex problem from digital-transformation spending, or a normal lumpy quarter that will fade. A week later, that quarter is still the only data point available, which is exactly why the committee's skeptical lenses (Burry, Taleb) hardened toward bearish rather than softening. NPL coverage at 109-110% is solid but thinner than some peers, giving less of a cushion if credit costs turn. This is a controlled company (Sy family/SM Group, roughly 40%+ combined stake); minority shareholders have no say in capital allocation, though the conservative capital ratios and rising, well-covered dividend suggest a shareholder-friendly record rather than a value-destructive one.

Nothing material has changed in the week since the last review: price is essentially flat (56.40 to 56.25), no new quarterly results (Q2 2026 is not due until late July/August), no new dividend declaration, and the only fresh news is a routine compliance-officer succession (effective July 16) plus digital-banking product updates (free My CBC fund transfers, a FIDO2 passkey rollout, and an AI banking assistant), none of which are fundamental catalysts. Neither the Buy nor Sell trigger below fired this week; the recommendation stays Buy because nothing in the underlying facts actually deteriorated, only the committee's read of the unresolved cost-to-income question hardened.

What would change the call:

  • Buy trigger (add on weakness): price falls further while NPL stays below 2% and CET1 stays above roughly 12%, i.e. the discount widens without fundamental deterioration; or the cost-to-income ratio reverts toward the 45% full-year 2025 level for two consecutive quarters while loan growth holds double digits, confirming the Q1 2026 opex jump was transient.
  • Sell trigger: NPL ratio rises toward the industry average (above roughly 2.5%), CET1 falls below roughly 12%, the dividend is cut or its multi-year raise streak is broken, or net income growth stays in the low single digits for three or more consecutive quarters while cost-to-income keeps climbing past 50% (confirming a structural profitability squeeze rather than a one-quarter blip).

PSE bank stocks can re-rate slowly; this is a multi-year holding thesis, not a trade. Analysis, not financial advice.

Committee review (July 19, 2026)

Five investor lenses judged this page's facts independently, each strictly inside its own framework.

Lens Signal Confidence Core argument
Ben Graham Bullish 68 At P56.25 the stock trades at 0.79x book with CAR 16.1%/CET1 15.2%, well above BSP minimums, giving a real margin of safety against senior claims. Earnings quality holds up: ROE has sat mid-teens for three straight years, NPL stays a tight 1.6% against a 3.2-3.4% industry average, and the dividend has risen for 5+ years at a conservative 24% payout.
Warren Buffett Bullish 74 A bank earning 15.5% ROE with a 4.61% NIM (versus Metrobank's 3.7%) and a 1.6% NPL ratio (versus 3.2% industry) has a real underwriting moat, and paying 0.79x book with a 5.36x P/E for that earnings power is the margin of safety Buffett looks for. Overcapitalization (16.1% CAR) and 5+ years of raised dividends under stable Sy family control show conservative, shareholder-aligned stewardship.
Michael Burry Bearish 58 Loans grew 16% YoY and NII 14% in Q1 2026, yet net income rose only 4%, cost-to-income jumped from 45% to 49% on vague "digital transformation" opex, and NPL coverage sits at 109-110%, well below Metrobank's 137-141%, while the loan book is unseasoned and expanding fast. A 0.79x P/B looks cheap on paper, but rapid loan growth paired with thin reserves and decelerating earnings quality is exactly the setup where reported NPLs understate real credit risk until it shows up later.
Nassim Taleb Bearish 62 A bank growing loans 16% YoY (vs peer's 9%) while NPL coverage sits at just 110%, thinner than Metrobank's 137-141%, is building tail risk into the loan book precisely when it's least covered. Cost-to-income jumping from 45% to 49% in one quarter alongside net income growth decelerating to just 4% shows negative convexity: the balance sheet is expanding faster than earnings can absorb a shock. Cheap P/E and P/B don't compensate for fragility.
Stanley Druckenmiller Neutral 42 Q1 2026 net income grew just 4% YoY despite loans +16% and NII +14%, because cost-to-income jumped from 45% to 49%. NIM (4.61%) and CAR (16.1%) still beat peers, but there's no near-term catalyst: no Q2 results yet, no fresh dividend since April, and the last week of news is non-financial (compliance hire, app features, AI assistant, an award). Cheap multiples don't matter without a trigger to re-rate the stock now.

Conferred call: Hold (2 bullish, 2 bearish, 1 neutral, a genuine split). This disagrees with the page's Buy Recommendation. Nothing in the underlying facts changed from the July 12 run, but Burry flipped from bullish to bearish: with a full week gone by and still no Q2 print to confirm the cost-to-income jump was transient, the "wait and see" read hardened into "the balance sheet's thin NPL coverage plus unseasoned fast loan growth is the real risk," which tipped the framework-count from majority-bullish to an even split. Checked against Brain/concepts/stock-trading-strategy-and-rules.md: this remains a multi-year value/income thesis with no confirmed technical catalyst, not a rulebook conflict, but the split itself argues for patience over urgency at this price rather than adding.

Shared flip trigger: Q2 2026 results showing cost-to-income reverting toward 45% and net income growth reaccelerating above 10% YoY would move Burry, Taleb, and Druckenmiller back toward bullish; a second straight quarter above 49% cost-to-income would confirm the bearish case and likely tip the page's own Recommendation to Hold.

Review history

Date Price Recommendation
July 10, 2026 56.35 Buy (value-plus-income pick; watch the Q1 2026 cost-to-income jump)
July 12, 2026 56.40 Buy (value-plus-income pick; watch the Q1 2026 cost-to-income jump)
July 19, 2026 56.25 Buy (unchanged; committee split to Hold, awaiting Q2 2026 results)

Sources